Clinical Trials
1,072 trialsControlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer
University of Southern California
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OCTANE
University Health Network, Toronto
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
OHSU Knight Cancer Institute
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
M.D. Anderson Cancer Center
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
ONE
Fred Hutchinson Cancer Center
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Case Comprehensive Cancer Center
BIO-PROSA
Regina Elena Cancer Institute
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
University of Southern California
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
American Society of Clinical Oncology
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Alliance for Clinical Trials in Oncology
Effect of CKC and WS Exercises on Postural Stability in Unilateral Post Mastectomy Lymphedema
Cairo University
Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
POCEB
University of Rochester
Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer
Hellenic Cooperative Oncology Group
NIGHT-SCAN
Assistance Publique - Hôpitaux de Paris
riboADHERE
Institute of Oncology Ljubljana
Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery
M.D. Anderson Cancer Center
Capecitabine in ER+/HER2-negative Breast Cancer
University Health Network, Toronto
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer
City of Hope Medical Center
Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer
St. Olavs Hospital
TALES
University of California, San Francisco
A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer
Duke University
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Mayo Clinic
ReDCoAT
NYU Langone Health
PROMESSE
Institut du Cancer de Montpellier - Val d'Aurelle
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
SKYPE2
Institut du Cancer de Montpellier - Val d'Aurelle
SIGHER
Centre Paul Strauss
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
The Methodist Hospital Research Institute
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Emory University
LYMPH
University Hospital, Basel, Switzerland
Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study
Ohio State University Comprehensive Cancer Center
ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC
Dana-Farber Cancer Institute
Breast Cancer Education to Prisoner Women
Hitit University
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
PREHAB KINELGD
Institut du Cancer de Montpellier - Val d'Aurelle
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Memorial Sloan Kettering Cancer Center
Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
THE EFFECT OF WHATSAPP-BASED EX-PLISSIT MODEL SEXUAL COUNSELING ON SEXUAL FUNCTION AND SEXUAL DISTRESS IN BREAST CANCER SURVIVORS
Karamanoğlu Mehmetbey University
Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.
University Medical Center Groningen
Study of Radiation Exposure and Bilateral Breast Cancer
Memorial Sloan Kettering Cancer Center
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Memorial Sloan Kettering Cancer Center
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
University of Michigan Rogel Cancer Center
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction
Ohio State University Comprehensive Cancer Center
QT-RIBRATING
CMC Ambroise Paré